Neutrophils involved in the inflammatory response degenerate, leaving behind extracellular
DNA,2 which increases the viscosity and adhesive properties of mucus3
In vitro, Pulmozyme cleaves neutrophil-derived DNA, which has been
shown to reduce sputum viscoelasticity3,4
Chmiel JF, Konstan MW. Anti-inflammatory medications for cystic fibrosis lung disease: selecting
the most appropriate agent. Treat Respir Med. 2005;4:255-273.
Puchelle E, de Bentzmann S, Zahm JM. Physical and functional properties of airway secretions in
cystic fibrosis—therapeutic approaches.
Respiration. 1995;62(suppl 1):2-12.
King M. In: Rubin BK, van der Schans CP, eds. Therapy for
Mucus-Clearance Disorders. New York, NY: Marcel Dekker Inc; 2004:201-224.